Logo

Ansa Biotechnologies

EnPlusOne Biosciences on Path Towards Commercial Enzymatic RNA Synthesis
Premium

The latest George Church startup says its platform technology can deliver enzymatically synthesized RNA at a commercial scale in the near future.

Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service
Premium

The University of California, Berkeley spinout hopes to stand out in the synthetic DNA race using its polymerase-nucleotide conjugation approach.

Ansa Biotechnologies Closes $68M Series A Financing

The University of California, Berkeley spinout plans to use the funding to accelerate development of its enzymatic DNA synthesis technology.

DNA Data Storage Alliance to Work on Interoperability, Industry Roadmap

Illumina, Twist Bioscience, Western Digital, and Microsoft are teaming up with others to make DNA-based data storage technologies interoperable.

Ansa Biotechnologies Raises $7.9M in Seed Funding

The funding will allow the company to accelerate development of its DNA synthesis technology, hire staff, build an R&D facility, and establish industrial partnerships.

Breaking News
The Scan

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Targets Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.